FundedIQ

Recently Funded Series Unknown Biotechnology Startups

Updated Sep 2026

Funded Series Unknown Biotechnology startups number 2,036 in FundedIQ, tracked with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Series Unknown Biotechnology startup funding landscape, along with the 100 most recently funded Series Unknown Biotechnology startups.

Cambridge and New York hold the deepest concentrations of these companies. Series Unknown Biotechnology startups closed 1,495 funding rounds over the last 24 months, 762 of them in the last 12 months, and raised $56B in disclosed capital. The median disclosed round is $5.8M, with the middle half of rounds falling between $1.8M and $27M.

Biotechnology ventures in Cambridge and New York often maintain small teams. These lean operations attract strategic backing from Eli Lilly and the National Institutes of Health. Such a profile indicates early stage development where the primary value lies in intellectual property rather than operational scale. This makes them ideal targets for specialized partners seeking nascent research.

Series Unknown Biotechnology funded startup statistics

Funded Series Unknown Biotechnology startups
2,036
tracked in the database
Funding rounds, last 12 months
762
1,495 over 24 months
Disclosed capital raised, 24 months
$56B
1,306 of 1,495 rounds disclosed an amount
Median round size
$5.8M
middle half $1.8M to $27M

Most recent funding round on record: Sep 2026. Investors appearing most often across Biotechnology funding rounds: Eli Lilly, RA Capital Management, BroadOak Capital Partners, EIC Accelerator, Gaingels.

100 most recently funded Series Unknown Biotechnology startups

100 of 2,036

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

C
Barcelona, Spain · Biotechnology
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…
Series Unknown ·
$4.2M
S
Beverly, United States · Biotechnology
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
Series Unknown ·
$960k
V
Cambridge, United Kingdom · Biotechnology
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Series Unknown ·
$23M
X
San Diego, United States · Biotechnology
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Series Unknown ·
$3.0M
A
Newton, United States · Biotechnology
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Series Unknown ·
$39M
M
Cambridge, United States · Biotechnology
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential…
Series Unknown ·
Undisclosed
B
Richmond, United States · Biotechnology
BRAINBox provides objective evidence of injury and prediction of patient recovery. BRAINBox Solutions'…
Series Unknown ·
Undisclosed
G
Ann Arbor, United States · Biotechnology
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It…
Series Unknown ·
$6.0M
S
Baltimore, United States · Biotechnology
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins focused on…
Series Unknown ·
$3.1M
A
Carlsbad, United States · Biotechnology
ALZpath is a biotech organization that offers innovative diagnostic options for Alzheimer's disease.
Series Unknown ·
$8.4M
H
Hanhe Biotechnology
Minhang, China · Biotechnology
Hanhe Biotechnology is a high-tech enterprise specializing in biorefining and new materials research and…
Series Unknown ·
Undisclosed
A
Seattle, United States · Biotechnology
Aptevo Therapeutics is a biotech company based in Seattle that focuses on developing new treatments for…
Series Unknown ·
$1.5M
B
Abingdon, United Kingdom · Biotechnology
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Series Unknown ·
$3.5M
C
Ponte Vedra Beach, United States · Biotechnology
Cadrenal Therapeutics is a late-stage biopharmaceutical company developing tecarfarin, an oral therapeutic…
Series Unknown ·
$3.0M
C
Rehovot, Israel · Biotechnology
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Series Unknown ·
$2.6M
I
Paterna, Spain · Biotechnology
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Series Unknown ·
$2.8M
O
Göteborg, Sweden · Biotechnology
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Series Unknown ·
$1.4M
P
Parnell, New Zealand · Biotechnology
Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and…
Series Unknown ·
$7.5M
P
Boston, United States · Biotechnology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to…
Series Unknown ·
$50M
T
Morgan Hill, United States · Biotechnology
Tenon Medical, a biotech firm specializing in enhancing surgical solutions for the SI joint, was established…
Series Unknown ·
$4.2M
4
Emeryville, United States · Biotechnology
4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes…
Series Unknown ·
$200M
C
London, United Kingdom · Biotechnology
Concert Bio helps businesses create optimal microbial communities.
Series Unknown ·
$130k
N
Fort Lee, United States · Biotechnology
Nuvectis Pharma is a biopharmaceutical company focused on creating new targeted treatments for cancer. The…
Series Unknown ·
$100M
S
Holland, United States · Biotechnology
Shoulder Innovations is a medical device company that has developed inset glenoid fixation technology,…
Series Unknown ·
$45M
Z
Oslo, Norway · Biotechnology
Zelluna Immunotherapy AS is a privately owned Norwegian biopharmaceutical company founded in 2016 focused on…
Series Unknown ·
$1.6M
D
Cambridge, United States · Biotechnology
Decoy Therapeutics is a preclinical stage biotech company building a pandemic preparedness drug development…
Series Unknown ·
$3.5M
E
Episurf Medical
Stockholm, Sweden · Biotechnology
Episurf is a medical company that focuses on helping people with painful joint injuries have a more active,…
Series Unknown ·
Undisclosed
H
Ålesund, Norway · Biotechnology
Hofseth BioCare's key goal is to offer high benefit added biomarine elements for human applications. Through…
Series Unknown ·
$15M
L
Daejeon, South Korea · Biotechnology
Lego Chem Bioscience , a company created by people with dreams and enthusiasm for global new drug…
Series Unknown ·
$214M
M
Toronto, Canada · Biotechnology
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Series Unknown ·
$4.4M
S
San Francisco, United States · Biotechnology
Siren Biotechnology combines AAV gene therapy and cytokine immunotherapy into a new method for treating…
Series Unknown ·
$8.0M
A
San Francisco, United States · Biotechnology
ALX Oncology is a biotech company focused on creating groundbreaking cancer immunotherapy treatments. It…
Series Unknown ·
$10M
A
Chuncheon, South Korea · Biotechnology
April Bio is a drug development company that develops antibodies and long-acting biologics.
Series Unknown ·
$124M
E
Monrovia, United States · Biotechnology
eXoZymes focuses on creating enzymes and developing enzyme pathways that can function independently outside…
Series Unknown ·
$2.0M
I
Albuquerque, United States · Biotechnology
Picture a future where cancer can be identified at its early stages, enabling treatments that are…
Series Unknown ·
$2.6M
L
Amsterdam, Netherlands · Biotechnology
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Series Unknown ·
$45M
N
New York, United States · Biotechnology
Series Unknown ·
$250M
O
Optimeos Life Sciences
Princeton, United States · Biotechnology
Optimeos Life Sciences is a biotechnology company that enables the use of biologics, peptides, and RNA to…
Series Unknown ·
Undisclosed
P
Leiden, The Netherlands · Biotechnology
ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients…
Series Unknown ·
$59M
C
La Jolla, United States · Biotechnology
Series Unknown ·
$49M
C
Zug, Switzerland · Biotechnology
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
Series Unknown ·
$1.2M
H
Toronto, Canada · Biotechnology
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Series Unknown ·
$50M
M
Melbourne, Australia · Biotechnology
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Series Unknown ·
$50M
S
Salt Lake City, United States · Biotechnology
Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through…
Series Unknown ·
$10M
T
Dallas, United States · Biotechnology
Taysha Gene Therapies is dedicated to eliminating serious and life-threatening genetic diseases in the…
Series Unknown ·
$200M
T
Chellaston, United Kingdom · Biotechnology
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Series Unknown ·
$3.6M
Z
Wondelgem, Belgium · Biotechnology
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Series Unknown ·
$2.2M
A
Marina Del Rey, United States · Biotechnology
Armata Pharmaceuticals is a biotechnology company that is in the process of developing bacteriophage…
Series Unknown ·
$2.5M
A
ARMR Sciences
New York, United States · Biotechnology
ARMR Sciences develops immunotherapy-based biodefense solutions to prevent overdose from fentanyl and…
Series Unknown ·
Undisclosed
B
Shekef, Israel · Biotechnology
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
Series Unknown ·
$1.0M
D
New York, United States · Biotechnology
Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…
Series Unknown ·
$805M
I
Lausanne, Switzerland · Biotechnology
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Series Unknown ·
$490k
L
San Diego, United States · Biotechnology
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help…
Series Unknown ·
$625M
M
MannKind
Valencia, United States · Biotechnology
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development, and commercialization of…
Series Unknown ·
Undisclosed
M
Zug, Switzerland · Biotechnology
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Series Unknown ·
$200M
N
Boston, United States · Biotechnology
NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17, a intranasal antiviral…
Series Unknown ·
$34M
S
Sangamo Therapeutics
Richmond, United States · Biotechnology
Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into…
Series Unknown ·
Undisclosed
U
Amsterdam, The Netherlands · Biotechnology
uniQure is a leader in the field of gene therapy and had developed the first and currently the only gene…
Series Unknown ·
$259M
X
Gainesville, United States · Biotechnology
X-tosis is pioneering a novel approach to treat Alzheimer's and Parkinson's diseases by targeting…
Series Unknown ·
$2.7M
A
Nîmes, France · Biotechnology
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
Series Unknown ·
$1.7M
C
Copenhagen, Denmark · Biotechnology
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Series Unknown ·
$3.1M
E
Endure Biotherapeutics
San Diego, United States · Biotechnology
Endure Biotherapeutics develops engineered live biotherapeutics for the treatment of genetic and chronic…
Series Unknown ·
Undisclosed
N
NanoGhosts
Tel Aviv, Israel · Biotechnology
NanoGhosts’ technology is based on its founder’s research, that the Technion's commercial unit has patented…
Series Unknown ·
Undisclosed
N
Valbonne, France · Biotechnology
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Series Unknown ·
$6.9M
R
San Diego, United States · Biotechnology
Replicate Bioscience is a clinical-stage biotechnology company developing self-replicating RNA (srRNA)…
Series Unknown ·
$3.0M
I
Wilmington, United States · Biotechnology
iQure Pharma is a biotechnology company founded by entrepreneurs and ex-pharmaceutical executives that…
Series Unknown ·
Undisclosed
O
Paris, France · Biotechnology
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Series Unknown ·
Undisclosed
R
Tel Aviv, Israel · Biotechnology
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Series Unknown ·
$6.0M
R
Or Akiva, Israel · Biotechnology
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
Series Unknown ·
$6.5M
S
Alameda, United States · Biotechnology
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The…
Series Unknown ·
$25M
B
San Antonio, United States · Biotechnology
BioAffinity Technologies, Inc. has developed CyPath® Lung, a noninvasive test that accurately detects…
Series Unknown ·
$3.2M
D
Cambridge, United States · Biotechnology
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's…
Series Unknown ·
$200M
H
Blackfalds, Canada · Biotechnology
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Series Unknown ·
$260k
I
Caesarea, Israel · Biotechnology
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Series Unknown ·
$5.5M
N
Mont-saint-guibert, Belgium · Biotechnology
Nyxoah is a health-technology company focused on the development and commercialization of innovative…
Series Unknown ·
$15M
O
Bronx, United States · Biotechnology
Oligomerix is a biopharmaceutical company founded in 2006 by co-founders Eliot J. Davidowitz and James Moe.…
Series Unknown ·
$1.9M
S
Helsinki, Finland · Biotechnology
Solar Foods is a food-tech startup that focuses on utilizing a technology that involves using electricity to…
Series Unknown ·
$46M
S
Shinjuku, Japan · Biotechnology
SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU)…
Series Unknown ·
$13M
S
Palo Alto, United States · Biotechnology
Spot BioSystems is a bioengineering firm that specializes in personalized cancer treatments. The company's…
Series Unknown ·
$40M
V
Delft, The Netherlands · Biotechnology
Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins…
Series Unknown ·
$12M
E
Emmecell
Menlo Park, United States · Biotechnology
Emmecell is a biotechnology company that provides developing cell-based therapies.
Series Unknown ·
Undisclosed
I
Novomirgorod, Ukraine · Biotechnology
The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from…
Series Unknown ·
$40k
R
Bedford, United States · Biotechnology
At Rejoni, our team is working on developing solutions that minimize both acute and chronic risks associated…
Series Unknown ·
$25M
S
Boston, United States · Biotechnology
Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein…
Series Unknown ·
$38M
S
Jerusalem, Israel · Biotechnology
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Series Unknown ·
$13M
I
Schlieren, Switzerland · Biotechnology
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
Series Unknown ·
$190k
L
Tokyo, Japan · Biotechnology
LIFESCAPES is a researcher and manufacturer of brain-computer interface equipment. LIFESCAPES aims to use BMI…
Series Unknown ·
$3.7M
P
Sion, Switzerland · Biotechnology
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
Series Unknown ·
$1.1M
C
Vienna, United States · Biotechnology
CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of…
Series Unknown ·
$2.5M
A
Seattle, United States · Biotechnology
Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on breast cancer and other breast…
Series Unknown ·
$4.5M
A
Toronto, Canada · Biotechnology
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Series Unknown ·
$430k
C
Tempe, United States · Biotechnology
Capstone Holding is a diversified platform of building products businesses focused on distribution, brand…
Series Unknown ·
$20M
M
Brisbane, Australia · Biotechnology
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Series Unknown ·
$3.5M
P
Bromma, Sweden · Biotechnology
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
Series Unknown ·
$790k
P
Houston, United States · Biotechnology
PolyVascular is working on the development of transcatheter pulmonary valves made from medical-grade polymer…
Series Unknown ·
$50k
A
Lausanne, Switzerland · Biotechnology
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
Series Unknown ·
$4.0M
A
Seoul, South Korea · Biotechnology
The company is a spin-off from Asan Medical Center, University of Ulsan University, with a primary objective…
Series Unknown ·
$2.4M
A
Charlottesville, United States · Biotechnology
Adial Pharmaceuticals is a biopharmaceutical business in the clinical stages that specialises on the creation…
Series Unknown ·
$32M
B
Bangalore, India · Biotechnology
Biodimension is offering biofabricated human tissues as an efficient animal alternative testing solutions to…
Series Unknown ·
$840k
E
Markham, Canada · Biotechnology
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
Series Unknown ·
$2.5M

1,936 more funded startups

2036 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to Jun 2026). The full 2,036-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 2,036 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Countries with the most funded Series Unknown Biotechnology startups

Where funded Series Unknown Biotechnology startups are headquartered, by the country on the company record.

Where are funded Series Unknown Biotechnology startups located?

Where funded Series Unknown Biotechnology startups are based, by the city on the company record.

Top investors in Series Unknown Biotechnology startups

The investors named most often across funded Series Unknown Biotechnology startups.

Investor
Companies backed
Eli Lilly
5
RA Capital Management
3
BroadOak Capital Partners
2
EIC Accelerator
2
Gaingels
2
Michael J. Fox Foundation
2
National Institutes of Health
2
National Science Foundation
2

Counts companies in this segment that name the firm as a backer. Investor names entered the pipeline in July 2026, so they cover the companies funded since.

About the FundedIQ Series Unknown Biotechnology startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 2,036 funded Series Unknown Biotechnology startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (189 of 1,495 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Series Unknown Biotechnology startups is dated Sep 2026.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Series Unknown Biotechnology startups are there?

FundedIQ tracks 2,036 funded Series Unknown Biotechnology startups. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Series Unknown Biotechnology startups raised?

Series Unknown Biotechnology startups tracked by FundedIQ have raised $56B in disclosed capital across 1,495 funding rounds over the last 24 months, including 762 rounds in the last 12 months. 1,306 of those 1,495 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which countries have the most funded Series Unknown Biotechnology startups?

United States leads with 1,259 companies, ahead of United Kingdom (137), Canada (121) and France (68).

Which cities have the most funded Series Unknown Biotechnology startups?

Cambridge leads with 112 companies, then New York (70), San Diego (67) and San Francisco (46).

Which investors back the most Series Unknown Biotechnology startups?

Eli Lilly, RA Capital Management, BroadOak Capital Partners, EIC Accelerator and Gaingels appear most often across funded Series Unknown Biotechnology startups in the FundedIQ dataset. The count is the number of tracked companies naming each firm as a backer, so it reflects the companies on record rather than every deal a firm has ever done.

What is a typical funding round size for Series Unknown Biotechnology startups?

The median disclosed round over the last 24 months is $5.8M, and the middle half of rounds fall between $1.8M and $27M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

How often is the Series Unknown Biotechnology startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Series Unknown Biotechnology startups is dated Sep 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.